A Phase 1 Study in Healthy Volunteers to Evaluate the Drug-Drug Interaction Potential Between ALG-055009 and Statin Therapy(Ies)
Latest Information Update: 21 Feb 2025
At a glance
- Drugs ALG 055009 (Primary) ; Atorvastatin; Rosuvastatin
- Indications Non-alcoholic steatohepatitis
- Focus Pharmacokinetics
- Sponsors Aligos Therapeutics
- 17 Feb 2025 Status changed from active, no longer recruiting to completed.
- 08 Jan 2024 New trial record